| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 8e-10 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-09 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.19 | 6e-08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-07 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-07 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |